Overview
Jolinta Lin is a Radiation Oncologist in Atlanta, Georgia. Dr. Lin has been practicing medicine for over 14 years and is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Familial Pancreatic Cancer, Intraductal Papilloma, and Angiosarcoma.
Her clinical research consists of co-authoring 28 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 12 articles and participated in 1 clinical trial in the study of Breast Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1365 Clifton Road Northeast, BldgC, Atlanta, GA 30322
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Emory Winship Cancer Institute
Reshma Jagsi is a Radiation Oncologist in Atlanta, Georgia. Dr. Jagsi has been practicing medicine for over 24 years and is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Angiosarcoma, Triple-Negative Breast Cancer, and Lung Cancer.
Emory Winship Cancer Institute
Mylin Torres is a Radiation Oncologist in Atlanta, Georgia. Dr. Torres has been practicing medicine for over 22 years and is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Angiosarcoma, Triple-Negative Breast Cancer, and Intraductal Papilloma.
Emory Proton Therapy Center
Karen Godette is a Radiation Oncologist in Atlanta, Georgia. Dr. Godette has been practicing medicine for over 37 years and is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Prostate Cancer, Breast Cancer, Familial Prostate Cancer, and Angiosarcoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Lin isDistinguished. Learn about Breast Cancer.
- Advanced
- Anal CancerDr. Lin isAdvanced. Learn about Anal Cancer.
- AngiosarcomaDr. Lin isAdvanced. Learn about Angiosarcoma.
- Familial Pancreatic CancerDr. Lin isAdvanced. Learn about Familial Pancreatic Cancer.
- Intraductal PapillomaDr. Lin isAdvanced. Learn about Intraductal Papilloma.
- MesenchymomaDr. Lin isAdvanced. Learn about Mesenchymoma.
- Undifferentiated Pleomorphic Sarcoma
- Experienced
- Adult Soft Tissue SarcomaDr. Lin isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Bone TumorDr. Lin isExperienced. Learn about Bone Tumor.
- Brain TumorDr. Lin isExperienced. Learn about Brain Tumor.
- Cholangiocarcinoma (Bile Duct Cancer)
- Epithelioid SarcomaDr. Lin isExperienced. Learn about Epithelioid Sarcoma.
- Fibrolamellar CarcinomaDr. Lin isExperienced. Learn about Fibrolamellar Carcinoma.